Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Validation and Reliability of the Parents Assessment of Protective Factors Survey

23. september 2021 opdateret af: Perran Boran, Marmara University

Strengthening Families to Prevent Child Neglect and Abuse With Community Based Protective Approaches: Culturally Appropriate Program Development and Educational Design

Neglect and abuse, which have a devastating effect on children, can be prevented with community-based education programs aimed at strengthening families. The study aimed to validate and determine reliability of the "Parents Assessment of Protective Factors (PAPF) survey" and to develop a culturally appropriate program and educational design for strengthening families.

Studieoversigt

Status

Ikke rekrutterer endnu

Betingelser

Detaljeret beskrivelse

The American Center for Social Policy Studies (CSSP) Center for Quality Improvement in Early Childhood (QIC_EC) defined protective factors that will form the basis of programs designed to prevent neglect and abuse, with community-based approaches. Community-based programs for primary prevention should be developed to prevent neglect and abuse, before it occurs. Existing studies in our country show that there is rarely a focus on preventing adverse childhood experiences with primary preventive approaches. Most of the studies are school-based, and aimed at increasing awareness of children and families about abuse.

This study aimed to evaluate the Turkish translation of the PAPF survey for validity and reliability and to adapt a culturally appropriate program and educational design for strengthening families, with a multidisciplinary team.

In the first step of the study, Turkish validity and reliability of the Parents Assessment of Protective Factors (PAPF) survey, will be conducted and applied to parents to determinate the protective factors. Turkish version of Adverse Childhood Experience Questionnaire (ACE), will be applied simultaneously with the PAPF survey, to identify adverse childhood experiences of parents that might affect parental resilience, parenting characteristics, and family dynamics.

In the second phase of the study, community-based family education programs that are currently being implemented in different countries will be reviewed by a multidisciplinary team (healthcare professionals, social workers and non-governmental organizations). A culturally appropriate educational primary prevention program for child neglect and abuse will be developed.

Undersøgelsestype

Observationel

Tilmelding (Forventet)

500

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

      • Istanbul, Kalkun
        • Marmara University School of Medicine

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 55 år (Voksen)

Tager imod sunde frivillige

Ja

Køn, der er berettiget til at studere

Alle

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

Parents of children aged between 0 to 8 years

Beskrivelse

Inclusion Criteria:

  • Parents of children aged between 0 to 8 years
  • Ability to read and complete the self-assessment questionnaires

Exclusion Criteria:

  • Parents who do not give consent to participate in the study

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Turkish Validation of The Parents Assessment of Protective Factors (PAPF) Survey
Tidsramme: Baseline
Parents Assessment of Protective Factors (PAPF) Survey will be validated
Baseline
Turkish Reliability of The Parents Assessment of Protective Factors (PAPF) Survey
Tidsramme: Baseline
Parents Assessment of Protective Factors (PAPF) Survey will be tested for reliability
Baseline
Turkish Reliability of The Parents Assessment of Protective Factors (PAPF) Survey
Tidsramme: at 6 months
Parents Assessment of Protective Factors (PAPF) Survey will be tested for reliability
at 6 months

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Subscale scores for each protective factors
Tidsramme: Baseline
Parents Assessment of Protective Factors (PAPF) Survey subscale scores will be computed. Higher scores indicate greater protective factors.
Baseline
Protective Factors Index (PFI)
Tidsramme: Baseline
Parents Assessment of Protective Factors (PAPF) Survey total scores will be summed
Baseline
Adverse Childhood Events
Tidsramme: Baseline

Adverse Childhood Events will be measured with Adverse Childhood Events Questionnaire.

Higher scores indicate increased exposure to trauma, which have been associated with a greater risk of negative consequences.

Baseline

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Forventet)

1. oktober 2021

Primær færdiggørelse (Forventet)

1. oktober 2022

Studieafslutning (Forventet)

1. oktober 2023

Datoer for studieregistrering

Først indsendt

23. september 2021

Først indsendt, der opfyldte QC-kriterier

23. september 2021

Først opslået (Faktiske)

4. oktober 2021

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

4. oktober 2021

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

23. september 2021

Sidst verificeret

1. september 2021

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • 09.2021.848

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

IPD-planbeskrivelse

Requests for wider sharing of data (for example in response to publications about the study and willingness to share), will be addressed on a case-by-case basis. Any data sharing request will be made to investigators through a pre-defined data requisition form. This form will contain information about the applicant, institution, purpose of data request, study objectives, ethical clearance of the study, etc. Once a request has been made the data governance body will discuss if that request was appropriate; data will be released following signing of the data sharing agreement. The data will be stored on the Marmara University servers and not be deposited in any 'community' database.

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Familie

  • Simon Fraser University
    University of British Columbia; McMaster University; University of Victoria; Public Health Agency of Canada (PHAC) og andre samarbejdspartnere
    Afsluttet
    Effektiviteten af ​​Nurse-Family Partnership (NFP) i BC
    Canada
  • Eva Morava-Kozicz
    Ikke rekrutterer endnu
    SLC35A2-CDG - Solute Carrier Family 35 Medlem A2 Medfødt glykosyleringslidelse
    Forenede Stater
  • Hospital Ruber Internacional
    Rekruttering
    Refraktær epilepsi | SLC35A2-CDG - Solute Carrier Family 35 Medlem A2 Medfødt glykosyleringslidelse
    Spanien
3
Abonner